Neuromodulation Devices Market Is Estimated to Reach a Value of US $7.1 Bn by 2018, Expanding at a CAGR of 14.4% in the Period from 2012 to 2018
The neuromodulation devices market is oligopolistic in nature with the top four companies representing nearly 91% of the overall market, finds Transparency Market Research (TMR) in a new study. The key players in the global neuromodulation devices market are Boston Scientific, Cyberonics, Medtronic, and St. Judes Medical.
View full press release